Skip to main content
. 2019 Sep 18;13:3307–3319. doi: 10.2147/DDDT.S211443

Figure 4.

Figure 4

The cell viability of 3T3 cells treated with NLCs and drugs solution using the MTT assay. (Data represents the mean±SD, n=6). *p<0.05.

Abbreviations: NLCs, nanostructured lipid carriers; RVC, ropivacaine; DMDT, dexmedetomidine; TPGS, tocopheryl polyethylene glycol 1000 succinate; HA, hyaluronic acid.